Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis
- PMID: 31452022
- PMCID: PMC6763516
- DOI: 10.1007/s10286-019-00628-6
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis
Abstract
Purpose: To review the management of gastrointestinal symptoms in patients with hereditary transthyretin amyloidosis, discussing diagnostic evaluations, assessment of disease progression and therapeutic strategies that could be implemented in routine practice.
Methods: Literature review. Key search terms included "gastrointestinal symptoms", "autonomic neuropathy", "hereditary transthyretin amyloidosis" and "familial amyloid polyneuropathy".
Results: Gastrointestinal disturbances are a common and serious manifestation of hereditary transthyretin amyloidosis, with significant effects on patients' quality of life and demonstrating a strong association with mortality. Gastrointestinal involvement is more often subclinical in the early stages of the disease, although in some patients gastric and/or bowel abnormalities may be the inaugural symptoms. In both cases, under-recognition, delayed investigation and suboptimal treatment frequently occur. A clear understanding of the mechanisms underlying gastrointestinal dysfunction in hereditary transthyretin amyloidosis is still lacking, but similar to diabetic enteropathy, multiple pathophysiological alterations seem to play a role.
Conclusions: Early detection and treatment of gastrointestinal disturbances is key to the successful treatment of this devastating disease. Gastroenterologists play a valuable role in both the diagnosis and the timely management of gastrointestinal symptoms in hereditary transthyretin amyloidosis and should, therefore, be part of a multidisciplinary and comprehensive approach to this disorder.
Keywords: Amyloidosis; Diarrhoea; Gastroparesis; Malabsorption; Transthyretin.
Conflict of interest statement
Dr. Obici declares speaker and consultation honoraria from Pfizer, Alnylam and Akcea. Dr. Suhr declares speaker and consultation honoraria from Pfizer, Alnylam, Akcea and Intellia.
Similar articles
-
Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):73-81. doi: 10.1080/17474124.2018.1397511. Epub 2017 Nov 20. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29073801
-
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.Eur J Gastroenterol Hepatol. 2021 May 1;33(5):613-622. doi: 10.1097/MEG.0000000000002030. Eur J Gastroenterol Hepatol. 2021. PMID: 33394808 Review.
-
THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.Orphanet J Rare Dis. 2014 Apr 27;9:61. doi: 10.1186/1750-1172-9-61. Orphanet J Rare Dis. 2014. PMID: 24767411 Free PMC article.
-
Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).Clin Auton Res. 2019 Apr;29(2):245-251. doi: 10.1007/s10286-018-0514-2. Epub 2018 Mar 6. Clin Auton Res. 2019. PMID: 29511897 Review.
-
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.Clin Auton Res. 2024 Jun;34(3):341-352. doi: 10.1007/s10286-024-01038-z. Epub 2024 May 20. Clin Auton Res. 2024. PMID: 38769233
Cited by
-
Prevalence and determinants of iron deficiency in cardiac amyloidosis.ESC Heart Fail. 2022 Apr;9(2):1314-1327. doi: 10.1002/ehf2.13818. Epub 2022 Feb 6. ESC Heart Fail. 2022. PMID: 35128833 Free PMC article.
-
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):668-678. doi: 10.1136/jnnp-2021-327909. Epub 2022 Mar 7. J Neurol Neurosurg Psychiatry. 2022. PMID: 35256455 Free PMC article. Review.
-
Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M.Front Aging Neurosci. 2022 Jan 26;13:786322. doi: 10.3389/fnagi.2021.786322. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35153720 Free PMC article.
-
Clinicopathological and Fecal Proteome Evaluations in 16 Dogs Presenting Chronic Diarrhea Associated with Lymphangiectasia.Vet Sci. 2021 Oct 19;8(10):242. doi: 10.3390/vetsci8100242. Vet Sci. 2021. PMID: 34679072 Free PMC article.
-
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.Eur J Neurol. 2024 Sep;31(9):e16384. doi: 10.1111/ene.16384. Epub 2024 Jul 10. Eur J Neurol. 2024. PMID: 38988097 Free PMC article.
References
-
- Wixner J, Tornblom H, Karling P, Anan I, Lindberg G. Abnormal small bowel motility in patients with hereditary transthyretin amyloidosis. Neurogastroenterol Motil. 2018;30(9):e13354. - PubMed
-
- Wixner J, Suhr OB, Anan I. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years. Expert Rev Gastroenterol Hepatol. 2018;12(1):73–81. - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous